Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.
<h4>Background</h4>Immunosuppressed individuals present serious morbidity and mortality from influenza, therefore it is important to understand the safety and immunogenicity of influenza vaccination among them.<h4>Methods</h4>This multicenter cohort study evaluated the immuno...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/a521253f5a8a48878f105bf9684f2625 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:a521253f5a8a48878f105bf9684f2625 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:a521253f5a8a48878f105bf9684f26252021-11-18T07:34:46ZImmunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.1932-620310.1371/journal.pone.0027214https://doaj.org/article/a521253f5a8a48878f105bf9684f26252011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22087267/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Immunosuppressed individuals present serious morbidity and mortality from influenza, therefore it is important to understand the safety and immunogenicity of influenza vaccination among them.<h4>Methods</h4>This multicenter cohort study evaluated the immunogenicity and reactogenicity of an inactivated, monovalent, non-adjuvanted pandemic (H1N1) 2009 vaccine among the elderly, HIV-infected, rheumatoid arthritis (RA), cancer, kidney transplant, and juvenile idiopathic arthritis (JIA) patients. Participants were included during routine clinical visits, and vaccinated according to conventional influenza vaccination schedules. Antibody response was measured by the hemagglutination-inhibition assay, before and 21 days after vaccination.<h4>Results</h4>319 patients with cancer, 260 with RA, 256 HIV-infected, 149 elderly individuals, 85 kidney transplant recipients, and 83 with JIA were included. The proportions of seroprotection, seroconversion, and the geometric mean titer ratios postvaccination were, respectively: 37.6%, 31.8%, and 3.2 among kidney transplant recipients, 61.5%, 53.1%, and 7.5 among RA patients, 63.1%, 55.7%, and 5.7 among the elderly, 59.0%, 54.7%, and 5.9 among HIV-infected patients, 52.4%, 49.2%, and 5.3 among cancer patients, 85.5%, 78.3%, and 16.5 among JIA patients. The vaccine was well tolerated, with no reported severe adverse events.<h4>Conclusions</h4>The vaccine was safe among all groups, with an acceptable immunogenicity among the elderly and JIA patients, however new vaccination strategies should be explored to improve the immune response of immunocompromised adult patients. (ClinicalTrials.gov, NCT01218685).João L MiragliaEdson AbdalaPaulo M HoffAndré M LuizDanise S OliveiraCarla G S SaadIeda M M LaurindoAna T R VisoAngela TayraLígia C PierrottiLuiz S AzevedoLúcia Maria A CamposNádia E AikawaMaria do Carmo S T TimenetskyExpedito LunaMaria Regina A CardosoJosé da S GuedesIsaias RawJorge KalilAlexander R PreciosoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 11, p e27214 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q João L Miraglia Edson Abdala Paulo M Hoff André M Luiz Danise S Oliveira Carla G S Saad Ieda M M Laurindo Ana T R Viso Angela Tayra Lígia C Pierrotti Luiz S Azevedo Lúcia Maria A Campos Nádia E Aikawa Maria do Carmo S T Timenetsky Expedito Luna Maria Regina A Cardoso José da S Guedes Isaias Raw Jorge Kalil Alexander R Precioso Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. |
| description |
<h4>Background</h4>Immunosuppressed individuals present serious morbidity and mortality from influenza, therefore it is important to understand the safety and immunogenicity of influenza vaccination among them.<h4>Methods</h4>This multicenter cohort study evaluated the immunogenicity and reactogenicity of an inactivated, monovalent, non-adjuvanted pandemic (H1N1) 2009 vaccine among the elderly, HIV-infected, rheumatoid arthritis (RA), cancer, kidney transplant, and juvenile idiopathic arthritis (JIA) patients. Participants were included during routine clinical visits, and vaccinated according to conventional influenza vaccination schedules. Antibody response was measured by the hemagglutination-inhibition assay, before and 21 days after vaccination.<h4>Results</h4>319 patients with cancer, 260 with RA, 256 HIV-infected, 149 elderly individuals, 85 kidney transplant recipients, and 83 with JIA were included. The proportions of seroprotection, seroconversion, and the geometric mean titer ratios postvaccination were, respectively: 37.6%, 31.8%, and 3.2 among kidney transplant recipients, 61.5%, 53.1%, and 7.5 among RA patients, 63.1%, 55.7%, and 5.7 among the elderly, 59.0%, 54.7%, and 5.9 among HIV-infected patients, 52.4%, 49.2%, and 5.3 among cancer patients, 85.5%, 78.3%, and 16.5 among JIA patients. The vaccine was well tolerated, with no reported severe adverse events.<h4>Conclusions</h4>The vaccine was safe among all groups, with an acceptable immunogenicity among the elderly and JIA patients, however new vaccination strategies should be explored to improve the immune response of immunocompromised adult patients. (ClinicalTrials.gov, NCT01218685). |
| format |
article |
| author |
João L Miraglia Edson Abdala Paulo M Hoff André M Luiz Danise S Oliveira Carla G S Saad Ieda M M Laurindo Ana T R Viso Angela Tayra Lígia C Pierrotti Luiz S Azevedo Lúcia Maria A Campos Nádia E Aikawa Maria do Carmo S T Timenetsky Expedito Luna Maria Regina A Cardoso José da S Guedes Isaias Raw Jorge Kalil Alexander R Precioso |
| author_facet |
João L Miraglia Edson Abdala Paulo M Hoff André M Luiz Danise S Oliveira Carla G S Saad Ieda M M Laurindo Ana T R Viso Angela Tayra Lígia C Pierrotti Luiz S Azevedo Lúcia Maria A Campos Nádia E Aikawa Maria do Carmo S T Timenetsky Expedito Luna Maria Regina A Cardoso José da S Guedes Isaias Raw Jorge Kalil Alexander R Precioso |
| author_sort |
João L Miraglia |
| title |
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. |
| title_short |
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. |
| title_full |
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. |
| title_fullStr |
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. |
| title_full_unstemmed |
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. |
| title_sort |
immunogenicity and reactogenicity of 2009 influenza a (h1n1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/a521253f5a8a48878f105bf9684f2625 |
| work_keys_str_mv |
AT joaolmiraglia immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT edsonabdala immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT paulomhoff immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT andremluiz immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT danisesoliveira immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT carlagssaad immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT iedammlaurindo immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT anatrviso immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT angelatayra immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT ligiacpierrotti immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT luizsazevedo immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT luciamariaacampos immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT nadiaeaikawa immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT mariadocarmosttimenetsky immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT expeditoluna immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT mariareginaacardoso immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT josedasguedes immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT isaiasraw immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT jorgekalil immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients AT alexanderrprecioso immunogenicityandreactogenicityof2009influenzaah1n1inactivatedmonovalentnonadjuvantedvaccineinelderlyandimmunocompromisedpatients |
| _version_ |
1718423239766573056 |